Auburn Community Hospital (ACH) is the first institution in the United States to integrate Abbott’s Alinity h‐series into the ACH Core Laboratory. This cutting‐edge hematology automation system is set to transform the capabilities of the Auburn Laboratory. The new system will facilitate the seamless measurement of complete blood counts, a crucial healthcare test widely ordered for patients.
In addition to conducting complete blood counts, this new system will have significant benefits for our physicians and patients allowing for increased specificity in the screening of numerous disorders such as infections, anemia, immune system diseases, and blood cancers. Not only will the Lab offer complete blood counts but will do this with increased accuracy, speed, and efficiency, and places the ACH Core Lab on the level of the largest and most prestigious healthcare institutions and clinical laboratories in the world.
The ACH Laboratory has been working with Abbott on securing this new technology for over two years and has a long and established relationship with Abbott. The ACH Core Lab has been recognized by the Joint Commission and the Department of Health for its high level of performance, including an exceptionally high volume of tests performed annually, and maintaining operations during the pandemic while carrying out thousands of tests and allowing necessary surgeries to continue, while keeping patients and employees safe.

This new system is particularly important to ACH because the hospital will open a comprehensive cancer center Spring 2024 and will be breaking ground soon for the Auburn Heart Institute. “These patient groups, known for their complex blood samples, pose challenges in analysis and this advanced technology promises enhanced accuracy and efficiency which will allow for healthcare professionals treating cardiology patients or cancer patients better data to care for patients right in our own backyard,” stated Ronald Kirshner, MD, and Chair of the Auburn Heart Institute.
Dr. John Riccio, former Chief Medical Officer and Lab Director says, “This is truly an innovation that we’ve been waiting on for a long time. For Abbott to choose us to be their partner in release of this new technology is phenomenal.” This new system was approved by the U.S. Food and Drug Administration (FDA) in August 2023.
Neal Nash, managing director for Abbott shared, “Our longtime partnership with Auburn made for the right choice to unveil the next line of laboratory technology. When you launch something new, it’s the first time you’re doing it and you’re installing the first one, you want to make sure you’ve got the right partner who is going to work with you hand-in-hand who’s going to make sure it’s going to go very well.”
By securing this latest technology the ACH Lab will have the capability to process 119 CBCs per hour, and the Alinity HS slide maker stainer automates and standardizes the formerly manual blood smear creation process. This innovation holds particular significance in labs where time, resources, and staff are under strain. The Abbott Alinity systems are also designed for efficiency, conducting more tests in less space, delivering faster test results, and minimizing human errors—all contributing to improved care for a greater number of patients.
Dr. James Syrett, Auburn hospital’s chief medical officer, provided an example of a patient who requires regular blood transfusions. “Using the old system, this patient would need to wait two hours for results before receiving the transfusion. Now, with Abbott’s Alinity h-series technology, the results will be available in 20 minutes.”
“This investment by ACH is significant because it is another example of how a rural community hospital can be a model for other institutions who are committed to offering the best care for patients. Our lab, now equipped with cutting‐edge technology, empowers physicians with swift and accurate information, facilitating timely communication with patients eagerly awaiting results,” affirmed Scott Berlucchi, President & CEO of ACH.
John Bagenski, Technical Director of the ACH Core Laboratory, expressed excitement, stating, “We are thrilled to be the inaugural laboratory in the country integrating this state‐of‐the‐art hematology testing technology. ACH and Abbott share a longstanding commitment to enhancing patient care at every life stage. With the implementation of the Abbott system in Auburn, we are positioned to elevate the standard of quality care in our community and across New York state.”
Jessica Giacona, ACH Core Laboratory Supervisor stated that “Securing this new system is humbling because we are the first laboratory in the country to integrate this technology into our facility, and it is meaningful recognition of the quality of our lab and the amazing team that works here.”
Bagenski, Giacona, and the team collaborated with Abbott for several months, seamlessly integrating the new system into the ACH lab and undergoing comprehensive training on the Alinity‐h system at Abbott’s Training Center in Dallas, Texas.
Auburn Community Hospital (ACH) is a not‐for‐profit, 99‐bed acute care facility with a mission to provide compassionate quality care to our community. ACH is the sole provider of acute and general hospital services in Cayuga County and the surrounding areas located in the Finger Lakes region of Central New York including one of the highest rated 80‐bed Long Term Care and Rehabilitation Center in the state.
Call Out:
Auburn Community Hospital – Core Lab
- First in the U.S. to be Awarded Abbott Laboratories Newest & Most Advanced Laboratory Technology. (Alinity-h)
- Offer complete blood counts with increased accuracy and efficiency.
- Increased specificity for the screening of numerous disorders including infections, anemia, immune system diseases, and blood cancers.
- Places the ACH Core Lab on the level of the largest and most prestigious healthcare clinical laboratories in the world.
Peace of mind is paramount for healthcare providers. However, some physicians hesitate to report potential medical malpractice claims to their insurance carriers for fear of jeopardizing their coverage. This article aims to clarify the importance of timely reporting and dispel common misconceptions.
A new final rule from the United States Department of Labor (“DOL”) went into effect on March 11, 2024 that changes how to determine whether a worker is an employee or an independent contractor under the Fair Labor Standards Act (“FLSA”). Rescinding the 2021 rule under which two key factors – control over the work and opportunity for profit or loss – carried greater weight, the final rule applies a six-factor test to ensure that an employer’s classification of its workers complies with the protections of the FLSA, primarily appropriate minimum wage payments and entitlement to overtime.
Over the next 30 years, the Broad Street Hospital continued to expand to meet the needs of the community driving the need for a new site. In 1972, a 126-bed hospital opened its doors at 321 Genesee Street which serves as the hospital’s primary location today. Two years later, the Broad Street facility was converted into a skilled nursing facility, marking the beginning stages of Oneida Health’s healthcare system.




For many years we have lived with the concept that primary care is delivered by an office based physician who treats and coordinates all our care. The wisdom and experience primary care physicians have brought to this practice has been remarkable. Over the last several years environmental pressures have brought about an evolution in the Primary Care model leading to unique new access points for patients.
In the rapidly evolving landscape of healthcare staying at the forefront of medical advancements is crucial. Velocity Clinical Research, a global leader in conducting clinical trials with almost 100 sites worldwide, offers an 
Expert witness testimony is essential to all medical malpractice legal proceedings. Usually, without a medical expert, plaintiffs cannot proceed to trial, and defendants are usually doomed to an adverse jury verdict. Medical experts are recruited in many ways, even from proprietary companies that offer a diverse variety of experts.


Demand for ACH’s services, utilization and growth continues to increase as we bring acute, post-acute and preventive care to members of our community. What I am most proud of is according to a recent study by The University of Wisconsin Population Health Institute, Cayuga County has experienced remarkable year over year improvements in health outcomes vs. other NYS counties over the last 10 years despite numerous challenging health factors. That means as the only health system in the area we are making a difference in our community when it comes to health outcomes,” he said.
shopping” for their medical treatments, since the Cancer Center is connected to the main hospital. Combined with the partnership of excellent SUNY Upstate cancer physicians, this increased convenience for patients will provide for more efficient, cost effective, and quality care right in their own community. Dr. Komal Akhtar, Medical Director for the new Cancer Center, has extensive training in Internal Medicine, Hematology and Medical Oncology, and is a member of the American Society of Clinical Oncology. She expressed her excitement about the impact the new Cancer Center will have on the area served by ACH.
Alongside the addition of the Cancer Center, ACH is enhancing the level of cardiovascular care for its patients with the new Auburn Heart Institute. Located in a newly renovated wing on the third floor of ACH, this multimillion-dollar investment in cardiac care will be led by Dr. Ronald Kirshner, who was recently appointed as its chair and medical director. Dr. Kirshner recently served as the Chief of Cardiac Services and Cardiothoracic Surgery at Rochester Regional Health Sands Constellation Heart Institute for over 30 years, and his clinical interests and expertise include creating systems to drive healthcare efficiency and quality.
Another important addition to the team at ACH is Dr. James Syrett, who joined the hospital in May of 2023 as the Chief Medical Officer. Board certified in both Emergency Medicine and EMS Medicine, Dr. Syrett has become only the third physician within a 100 mile radius of Auburn to be certified by ImPACT Applications Inc., a leading provider of concussion management tools, which helps ensure healthcare providers have the necessary skills and knowledge to use the tools effectively. Utilizing his extensive experience in EMS and Emergency Medicine, as well as an interest in the emergency management of concussions. Dr Syrett will serve as the Medical Director of the new Auburn Concussion Clinic, which opened in October and is seeing patients next day when referred from other physicians. This gives patients immediate access to concussion specialists, which is unusual in this region.

We are planning a Heritage trip and have spent hours doing research. My daughter pulled up Chat GPT, gave it a few directions and in 30 seconds it listed an itinerary, things to visit, and lots of other info for consideration.